Operating Income: The income after operating expenses.
Lexicon Pharmaceuticals, Inc. (LXRX) had Operating Income of $-12.19M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$14.18M |
|
$-12.77M |
|
$0.01M |
|
$14.17M |
|
$26.37M |
|
|
Operating Income |
$-12.19M |
$-0.58M |
|
$-12.77M |
|
$-12.77M |
|
$-12.77M |
|
$-12.77M |
|
$-12.77M |
|
$-12.77M |
|
$-12.19M |
|
$-11.63M |
|
363.40M |
|
363.40M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$122.53M |
|
$1.98M |
|
$83.40M |
|
$205.93M |
|
$21.72M |
|
$56.51M |
|
$64.05M |
|
$85.77M |
|
$120.16M |
|
$75.62M |
|
$120.16M |
|
363.40M |
|
| Cash Flow Statement Financials | |
$-50.62M |
|
$108.19M |
|
$-45.57M |
|
$66.66M |
|
$78.66M |
|
$12.00M |
|
$9.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.64 |
|
-- |
|
-- |
|
0.32 |
|
0.47 |
|
99.93% |
|
-85.93% |
|
-85.93% |
|
-- |
|
-90.04% |
|
-90.04% |
|
$-50.62M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.06 |
|
6.08 |
|
14.81 |
|
-10.63% |
|
-16.89% |
|
-6.20% |
|
-7.23% |
|
$0.33 |
|
$-0.14 |
|
$-0.14 |
|